|
|
chromatin organization
|
GO:0006325 |
351 |
0.998
|
|
|
|
regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter
|
GO:0072366 |
1 |
0.996
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.988
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.986
|
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.980
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.979
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.979
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.975
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.972
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.956
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.955
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.947
|
|
|
|
intracellular estrogen receptor signaling pathway
|
GO:0030520 |
23 |
0.947
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
35 |
0.935
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.935
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.900
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.867
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.863
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
37 |
0.854
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.845
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.805
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
27 |
0.804
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.797
|
|
|
|
positive regulation of erythrocyte differentiation
|
GO:0045648 |
11 |
0.795
|
|
|
|
negative regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060633 |
3 |
0.778
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.769
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.756
|
|
|
|
histone h3 k9 modification
|
GO:0061647 |
11 |
0.751
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.724
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.708
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.706
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.704
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.699
|
Mouse |
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
4 |
0.680
|
|
|
|
regulation of intracellular estrogen receptor signaling pathway
|
GO:0033146 |
13 |
0.671
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.671
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.662
|
|
|
|
protein methylation
|
GO:0006479 |
74 |
0.662
|
|
|
|
protein alkylation
|
GO:0008213 |
74 |
0.629
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
54 |
0.573
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.558
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.552
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
3 |
0.546
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
3 |
0.545
|
|
|
|
carbon catabolite regulation of transcription from rna polymerase ii promoter
|
GO:0000429 |
3 |
0.534
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.527
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.509
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.490
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.477
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.473
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.464
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.462
|
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.455
|
|
|
|
mating
|
GO:0007618 |
1 |
0.453
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
47 |
0.452
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.452
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.451
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.441
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.436
|
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
27 |
0.432
|
|
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
3 |
0.431
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.429
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.425
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.422
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.397
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.396
|
|
|
|
positive regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060261 |
4 |
0.395
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.391
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.379
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.371
|
|
|
|
regulation of transcription by galactose
|
GO:0000409 |
1 |
0.364
|
|
|
|
positive regulation of immunoglobulin mediated immune response
|
GO:0002891 |
4 |
0.349
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.348
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.338
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.337
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
41 |
0.330
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.324
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.319
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.315
|
|
|
|
positive regulation of gluconeogenesis
|
GO:0045722 |
1 |
0.309
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.306
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061419 |
2 |
0.304
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.302
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.289
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.286
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.284
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.284
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.283
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.280
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
32 |
0.278
|
|
|
|
positive regulation of intracellular estrogen receptor signaling pathway
|
GO:0033148 |
5 |
0.274
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.272
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.271
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
3 |
0.261
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.261
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.259
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.259
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.248
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.243
|
Mouse |
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.242
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.240
|
|
|
|
adipose tissue development
|
GO:0060612 |
2 |
0.223
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.221
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.218
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.212
|
Mouse |
|
|
renal system development
|
GO:0072001 |
63 |
0.210
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.210
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.209
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.208
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.208
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.207
|
Mouse |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.203
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.200
|
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.200
|
|
|
|
regulation of gluconeogenesis by regulation of transcription from rna polymerase ii promoter
|
GO:0035947 |
1 |
0.198
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
18 |
0.197
|
|
|
|
response to estradiol
|
GO:0032355 |
23 |
0.196
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.195
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.193
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.192
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.187
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
9 |
0.185
|
|
|
|
regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060260 |
8 |
0.183
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.178
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.178
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.176
|
|
|
|
humoral immune response
|
GO:0006959 |
49 |
0.171
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.169
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
10 |
0.169
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.169
|
|
|
|
respiratory tube development
|
GO:0030323 |
20 |
0.168
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.167
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.167
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.166
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.162
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.161
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.159
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.157
|
|
|
|
regulation of dna templated transcription initiation
|
GO:2000142 |
9 |
0.155
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.154
|
|
|
|
system process
|
GO:0003008 |
349 |
0.153
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.152
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.152
|
|
|
|
positive regulation of glucocorticoid receptor signaling pathway
|
GO:2000324 |
1 |
0.151
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.151
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
22 |
0.150
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.150
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.149
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.149
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.149
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.148
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.146
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.145
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.144
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.144
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.144
|
|
|
|
positive regulation of feeding behavior
|
GO:2000253 |
1 |
0.140
|
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
3 |
0.138
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.137
|
|
|
|
lung development
|
GO:0030324 |
20 |
0.136
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.135
|
|
|
|
negative regulation of bile acid biosynthetic process
|
GO:0070858 |
3 |
0.132
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.130
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.129
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.129
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.129
|
|
|
|
amide biosynthetic process
|
GO:0043604 |
15 |
0.128
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.127
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.127
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.123
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.123
|
|
|
|
intracellular bile acid receptor signaling pathway
|
GO:0038185 |
1 |
0.119
|
|
|
|
negative regulation of g0 to g1 transition
|
GO:0070317 |
2 |
0.119
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.119
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.118
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.117
|
|
|
|
protein dna complex assembly
|
GO:0065004 |
64 |
0.117
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.116
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.113
|
|
|
|
smooth muscle cell differentiation
|
GO:0051145 |
8 |
0.113
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.112
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.111
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
5 |
0.111
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.110
|
|
|
|
response to glucagon
|
GO:0033762 |
1 |
0.109
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
45 |
0.109
|
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.109
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.108
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.108
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.108
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
47 |
0.106
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
22 |
0.103
|
|
|
|
response to hyperoxia
|
GO:0055093 |
4 |
0.103
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.102
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
4 |
0.102
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.101
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.100
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
42 |
0.100
|
|
|
|
glucose metabolic process
|
GO:0006006 |
45 |
0.099
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.099
|
Mouse |
|
|
regulation of muscle cell differentiation
|
GO:0051147 |
31 |
0.098
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.097
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.097
|
|
|
|
peptide metabolic process
|
GO:0006518 |
51 |
0.095
|
|
|
|
negative regulation of cholesterol storage
|
GO:0010887 |
4 |
0.094
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.093
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.093
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.093
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.093
|
|
|
|
protein demethylation
|
GO:0006482 |
17 |
0.092
|
|
|
|
positive regulation of b cell mediated immunity
|
GO:0002714 |
4 |
0.091
|
|
|
|
regulation of activin receptor signaling pathway
|
GO:0032925 |
14 |
0.090
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus
|
GO:1901522 |
2 |
0.090
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.090
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.088
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.087
|
|
|
|
respiratory system development
|
GO:0060541 |
22 |
0.087
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.085
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.085
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.084
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.084
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.083
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
28 |
0.082
|
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.082
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.081
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.081
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
4 |
0.079
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.078
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.078
|
|
|
|
positive regulation of interleukin 5 production
|
GO:0032754 |
3 |
0.078
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
10 |
0.078
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.077
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.077
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.076
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
39 |
0.076
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.076
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.076
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.075
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.075
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.074
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.073
|
Mouse |
|
|
macroautophagy
|
GO:0016236 |
39 |
0.072
|
|
|
|
organ induction
|
GO:0001759 |
4 |
0.071
|
|
|
|
nitrogen cycle metabolic process
|
GO:0071941 |
3 |
0.071
|
|
|
|
positive regulation of hormone biosynthetic process
|
GO:0046886 |
4 |
0.071
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.070
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.069
|
|
|
|
cell aggregation
|
GO:0098743 |
1 |
0.069
|
|
|
|
histone lysine demethylation
|
GO:0070076 |
14 |
0.069
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.069
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.067
|
|
|
|
histone demethylation
|
GO:0016577 |
15 |
0.067
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.067
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.067
|
|
|
|
cellular response to reactive oxygen species
|
GO:0034614 |
50 |
0.066
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
37 |
0.066
|
|
|
|
regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034243 |
13 |
0.065
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.064
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.064
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.064
|
Mouse |
|
|
positive regulation of autophagy
|
GO:0010508 |
24 |
0.064
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.063
|
|
|
|
negative regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0017055 |
2 |
0.063
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.063
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.062
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.061
|
|
|
|
regulation of receptor biosynthetic process
|
GO:0010869 |
15 |
0.061
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.060
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.060
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
18 |
0.060
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.060
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.059
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
1 |
0.059
|
|
|
|
regulation of autophagy
|
GO:0010506 |
52 |
0.058
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.058
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.058
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.058
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.058
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.058
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.058
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.057
|
|
|
|
b cell homeostasis
|
GO:0001782 |
1 |
0.057
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.057
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.056
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
9 |
0.056
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.056
|
|
|
|
negative regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0071930 |
2 |
0.055
|
|
|
|
hemoglobin biosynthetic process
|
GO:0042541 |
3 |
0.055
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.055
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.055
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.054
|
|
|
|
response to low density lipoprotein particle
|
GO:0055098 |
4 |
0.054
|
|
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
23 |
0.054
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.054
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.054
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.053
|
|
|
|
positive regulation of epithelial cell differentiation
|
GO:0030858 |
14 |
0.053
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.053
|
|
|
|
regulation of developmental growth
|
GO:0048638 |
30 |
0.053
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.052
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
3 |
0.052
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.052
|
|
|
|
positive regulation of glucose metabolic process
|
GO:0010907 |
12 |
0.052
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.052
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.052
|
|
|
|
negative regulation of developmental growth
|
GO:0048640 |
10 |
0.052
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.052
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.052
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
27 |
0.052
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.052
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
27 |
0.051
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.051
|
Mouse |
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
21 |
0.051
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.051
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.051
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.051
|
|
|
|
regulation of g0 to g1 transition
|
GO:0070316 |
2 |
0.050
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.050
|
Mouse |
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.050
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.050
|
|
|
|
dna templated transcription elongation
|
GO:0006354 |
25 |
0.050
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.050
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.049
|
|
|
|
regulation of multicellular organism growth
|
GO:0040014 |
8 |
0.049
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.049
|
|
|
|
glucan metabolic process
|
GO:0044042 |
22 |
0.049
|
|
|
|
negative regulation of smooth muscle cell differentiation
|
GO:0051151 |
2 |
0.049
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.049
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.049
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.048
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.048
|
|
|
|
peptidyl lysine dimethylation
|
GO:0018027 |
3 |
0.048
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
30 |
0.048
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
18 |
0.048
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
18 |
0.048
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.048
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
22 |
0.047
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.047
|
|
|
|
negative regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034244 |
4 |
0.047
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
29 |
0.047
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.047
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.047
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.046
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.046
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
3 |
0.046
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.046
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
59 |
0.045
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.045
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.044
|
|
|
|
dicarboxylic acid biosynthetic process
|
GO:0043650 |
4 |
0.044
|
|
|
|
positive regulation of dendrite morphogenesis
|
GO:0050775 |
3 |
0.044
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.043
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.043
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.043
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.043
|
|
|
|
negative regulation of cell fate commitment
|
GO:0010454 |
3 |
0.042
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.042
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.042
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
24 |
0.041
|
|
|
|
response to electrical stimulus
|
GO:0051602 |
1 |
0.041
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.041
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.041
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.041
|
Mouse |
|
|
zymogen activation
|
GO:0031638 |
70 |
0.041
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.041
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.040
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
2 |
0.040
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.040
|
|
|
|
chromatin mediated maintenance of transcription
|
GO:0048096 |
2 |
0.040
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.040
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.039
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.039
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.039
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.039
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.039
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.039
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
10 |
0.038
|
|
|
|
negative regulation of transcription factor import into nucleus
|
GO:0042992 |
17 |
0.038
|
|
|
|
pericardium development
|
GO:0060039 |
2 |
0.038
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.038
|
|
|
|
negative regulation of t cell apoptotic process
|
GO:0070233 |
4 |
0.037
|
|
|
|
histone h3 k27 demethylation
|
GO:0071557 |
3 |
0.037
|
|
|
|
n terminal protein amino acid modification
|
GO:0031365 |
13 |
0.037
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.037
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.037
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.037
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.037
|
|
|
|
muscle cell cellular homeostasis
|
GO:0046716 |
3 |
0.037
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.037
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.037
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.036
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.036
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.036
|
|
|
|
dendrite development
|
GO:0016358 |
24 |
0.036
|
|
|
|
autophagy
|
GO:0006914 |
88 |
0.036
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
80 |
0.036
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
92 |
0.036
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.036
|
|
|
|
negative regulation of blood circulation
|
GO:1903523 |
4 |
0.036
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
4 |
0.035
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.035
|
|
|
|
protein deacetylation
|
GO:0006476 |
38 |
0.035
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.035
|
|
|
|
protein deacylation
|
GO:0035601 |
39 |
0.035
|
|
|
|
cellular response to nutrient
|
GO:0031670 |
12 |
0.035
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.035
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
69 |
0.035
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
40 |
0.035
|
|
|
|
hair cell differentiation
|
GO:0035315 |
2 |
0.034
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.034
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.034
|
|
|
|
positive regulation of cell size
|
GO:0045793 |
3 |
0.034
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.034
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.034
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.034
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.034
|
|
|
|
cognition
|
GO:0050890 |
43 |
0.033
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.033
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.033
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.033
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.033
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.033
|
|
|
|
histone h3 k36 methylation
|
GO:0010452 |
5 |
0.033
|
|
|
|
memory
|
GO:0007613 |
3 |
0.033
|
|
|
|
lung cell differentiation
|
GO:0060479 |
1 |
0.033
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
43 |
0.033
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.032
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.032
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.032
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.032
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.032
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.032
|
Mouse |
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.032
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
19 |
0.032
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
22 |
0.032
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
3 |
0.031
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
73 |
0.031
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.031
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.031
|
|
|
|
transdifferentiation
|
GO:0060290 |
2 |
0.031
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.031
|
|
|
|
midgut development
|
GO:0007494 |
1 |
0.031
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.031
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.031
|
|
|
|
positive regulation of triglyceride biosynthetic process
|
GO:0010867 |
4 |
0.031
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.031
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.031
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.031
|
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
34 |
0.030
|
|
|
|
dendrite morphogenesis
|
GO:0048813 |
14 |
0.030
|
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
24 |
0.030
|
|
|
|
lymphatic endothelial cell fate commitment
|
GO:0060838 |
2 |
0.030
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.030
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.030
|
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
12 |
0.030
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.030
|
Mouse |
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.030
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.030
|
|
|
|
elastin metabolic process
|
GO:0051541 |
1 |
0.029
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
37 |
0.029
|
|
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
4 |
0.029
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.029
|
|
|
|
response to muscle activity
|
GO:0014850 |
0 |
0.029
|
|
|
|
epithelial cell fate commitment
|
GO:0072148 |
3 |
0.029
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.029
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.029
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.029
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
35 |
0.029
|
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.028
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
43 |
0.028
|
|
|
|
regulation of glucocorticoid receptor signaling pathway
|
GO:2000322 |
2 |
0.028
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.028
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.028
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.028
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.028
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.028
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.028
|
|
|
|
regulation of transcription involved in lymphatic endothelial cell fate commitment
|
GO:0060849 |
2 |
0.028
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.028
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.028
|
|
|
|
negative regulation of transcription by competitive promoter binding
|
GO:0010944 |
8 |
0.028
|
|
